Czech Republic - Renin-Angiotensin System Medicine Use
Since 2014, Czech Republic Renin-Angiotensin System Medicine Use was up 1% year on year. With 260.4 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, the country was number 3 comparing other countries in Renin-Angiotensin System Medicine Use. Czech Republic is overtaken by Germany, which was ranked number 2 at 358.2 Units (Defined Daily Dosage) Per Thousand Persons Per Day and is followed by Finland at 257.4 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Hungary lead the ranking with 369.7 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, that is +0.6% compared to 2018. Austria witnessed the best average annual growth at +10.2% per year, while Chile was the worst growing country at -3.5% per year.
Loading...
| Date | Units (Defined Daily Dosage) Per Thousand Persons Per Day |
|---|---|
| 2019 | 260.40 |
| 2018 | 250.50 |
| 2017 | 255.30 |
| 2016 | 255.00 |
| 2015 | 251.40 |
How does Czech Republic rank in Renin-Angiotensin System Medicine Use?
| # | 28 Countries | Units (Defined Daily Dosage) Per Thousand Persons Per Day | Last | YoY | 5‑years CAGR | |
|---|---|---|---|---|---|---|
| 1 |
#1
Hungary
|
370 | 2019 | +0.6 % | +0.6 % | View data |
| 2 |
#2
Germany
|
358 | 2019 | +3.4 % | +1.7 % | View data |
| 3 |
#3
Czech Republic
|
260 | 2019 | +4.0 % | +1.0 % | View data |
| 4 |
#4
Finland
|
257 | 2019 | +1.8 % | +2.8 % | View data |
| 5 |
#5
Slovenia
|
249 | 2019 | +0.8 % | -0.9 % | View data |